Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 3, 2012, Pages 487-492

  Parameshwaran, Kodeeswaran ^a   Irwin, Michael H ^a   Steliou, Kosta ^b,c   Pinkert, Carl A ^a  

^a AUBURN UNIVERSITY   (United States)

^b PhenoMatriX Inc   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Brain; Cellular stress; Mice; Reactive oxygen species; Rotenone

Indexed keywords

ANTIOXIDANT; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; NEUROPROTECTIVE AGENT; PMX 500 F; REACTIVE OXYGEN METABOLITE; ROTENONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRESS; ENDURANCE; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVATION; FOREBRAIN; LOCOMOTION; MESENCEPHALON; MOTOR COORDINATION; MOUSE; MUSCLE STRENGTH; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ROTAROD TEST;

ANIMALS; ANTIOXIDANTS; BRAIN; ELECTRON TRANSPORT COMPLEX I; HAZARDOUS SUBSTANCES; INSECTICIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MOTOR SKILLS; NEUROPROTECTIVE AGENTS; REACTIVE OXYGEN SPECIES; ROTENONE; STRESS, PHYSIOLOGICAL;

MUS;

EID: 84857699370     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.02.011     Document Type: Article

References (39)

1. Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P. Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 2003;157:409-14. (Pubitemid 36258596)
2. Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem 1999;274:16188-97.
3. Binukumar BK, Gupta N, Bal A, Gill KD. Protection of dichlorvos induced oxidative stress and nigrostriatal neuronal death by chronic coenzyme Q10 pretreatment. Toxicol Appl Pharmacol 2011;256:73-82.
4. Bjorling-Poulsen M, Andersen HR, Grandjean P. Potential developmental neurotoxicity of pesticides used in Europe. Environ Health 2008;7:50.
5. Brinkley BR, Barham SS, Barranco SC, Fuller GM. Rotenone inhibition of spindle microtubule assembly in mammalian cells. Exp Cell Res 1974;85:41-6.
6. Burns CJ, Beard KK, Cartmill JB. Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: an update. Occup Environ Med 2001;58:24-30. (Pubitemid 32096098)
7. Cannon MV, Dunn DA, Irwin MH, Brooks AI, Bartol FF, Trounce IA, et al. Xenomitochondrial mice: investigation into mitochondrial compensatory mechanisms. Mitochondrion 2011;11:33-9.
8. Chance B, Williams GR, Hollunger G. Inhibition of electron and energy transfer in mitochondria. I. Effects of Amytal, thiopental, rotenone, progesterone, and methylene glycol. J Biol Chem 1963;238:418-31.
9. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A 2000;59:229-34. (Pubitemid 30116510)
10. Costa LG, Giordano G, Guizzetti M, Vitalone A. Neurotoxicity of pesticides: a brief review. Front Biosci 2008;13:1240-9. (Pubitemid 351594708)
11. Eisenhofer G, Kopin IJ, Goldstein DS. Leaky catecholamine stores: undue waste or a stress response coping mechanism? Ann N Y Acad Sci 2004;1018:224-30. (Pubitemid 38951411)
12. Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull 1993;49:577-87. (Pubitemid 23243831)
13. Fleming SM, Zhu C, Fernagut PO, Mehta A, DiCarlo CD, Seaman RL, et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 2004;187:418-29. (Pubitemid 38610288)
14. Floor E, Leventhal PS, Wang Y, Meng L, Chen W. Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J Neurochem 1995;64:689-99.
15. Foster DW. The role of the carnitine system in human metabolism. Ann N Y Acad Sci 2004;1033:1-16. (Pubitemid 39656734)
16. Gutman M, Singer TP, Beinert H, Casida JE. Reaction sites of rotenone, piericidin A, and amytal in relation to the nonheme iron components of NADH dehydrogenase. Proc Natl Acad Sci U S A 1970;65:763-70.
17. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford: Oxford University Press; 1999.
18. Kumar V, Kinsella LJ. Healthy brain aging: effect of head injury, alcohol and environmental toxins. Clin Geriatr Med 2010;26:29-44.
19. Lapointe N, St-Hilaire M, Martinoli MG, Blanchet J, Gould P, Rouillard C, et al. Rotenone induces non-specific central nervous system and systemic toxicity. FASEB J 2004;18:717-9.
20. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 2003;278:8516-25. (Pubitemid 36800604)
21. Litteljohn D, Nelson E, Bethune C, Hayley S. The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice. Neurosci Lett 2011;502:186-91.
22. Marshall LE, Himes RH. Rotenone inhibition of tubulin self-assembly. Biochim Biophys Acta 1978;543:590-4. (Pubitemid 9043433)
23. Miyakawa T, Yamada M, Duttaroy A, Wess J. Hyperactivity and intact hippocampusdependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 2001;21:5239-50. (Pubitemid 32622949)
24. Moon Y, Lee KH, Park JH, Geum D, Kim K. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. J Neurochem 2005;93:1199-208. (Pubitemid 40776574)
25. Parameshwaran K, Irwin MH, Steliou K, Pinkert CA. D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment inmice. Rejuvenation Res 2010;13:729-35.
26. Park HY, Hertz-Picciotto I, Sovcikova E, Kocan A, Drobna B, Trnovec T. Neurodevelopmental toxicity of prenatal polychlorinated biphenyls (PCBs) by chemical structure and activity: a birth cohort study. Environ Health 2010;9:51.
27. Pinkert CA, Trounce IA. Generation of transmitochondrial mice: development of xenomitochondrial mice to model neurodegenerative diseases. Methods Cell Biol 2007;80:549-69.
28. Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. J Cereb Blood Flow Metab 2002;22:746-52. (Pubitemid 34596467)
29. Radad K, Rausch WD, Gille G. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem Int 2006;49:379-86. (Pubitemid 44119044)
30. Ren Y, Liu W, Jiang H, Jiang Q, Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 2005;280:34105-12. (Pubitemid 41443134)
31. Richter F, Hamann M, Richter A. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice. J Neurosci Res 2007;85:681-91.
32. Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;46:1275-84. (Pubitemid 26159286)
33. Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, et al. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 2003;74:589-97. (Pubitemid 37352081)
34. Sharma LK, Lu J, Bai Y. Mitochondrial respiratory complex I: structure, function and implication in human diseases. Curr Med Chem 2009;16:1266-77.
35. Silva MH, Gammon D. An assessment of the developmental, reproductive, and neurotoxicity of endosulfan. Birth Defects Res B Dev Reprod Toxicol 2009;86:1-28.
36. Smith GA, Heuer A, Dunnett SB, Lane EL. Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: Predicting l-DOPA-induced dyskinesia. Behav Brain Res 2012;226: 281-92.
37. Spivey A. Rotenone and paraquat linked to Parkinson's disease: human exposure study supports years of animal studies. Environ Health Perspect 2011;119:A259.
38. Swarnkar S, Singh S, Mathur R, Patro IK, Nath C. A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats. Toxicology 2010;272:17-22.
39. Swarnkar S, Singh S, Sharma S, Mathur R, Patro IK, Nath C. Rotenone induced neurotoxicity in rat brain areas: a histopathological study. Neurosci Lett 2011;501:123-7.